Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System
<!-- Name:DistributionId Value:8756001 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Chembio
Monkeypox Testing Market Report (2022 to 2030) – Abbott Laboratories Inc., QIAGEN NV,…
Pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Monkeypox Testing Market by Type (Polymerase Chain Reaction, Lateral Flow Assay, and Others) and…
Chembio Diagnostics Reports Second Quarter 2022 Financial Results
HAUPPAUGE, N.Y., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious…
Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel
HAUPPAUGE, N.Y., June 15, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today…
Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of…
HAUPPAUGE, N.Y., May 24, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today…
Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The…
HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its…